Maintaining Both Your Business and Your Sanity During the Pandemic
Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the...
Perspectives on a Post-pandemic World
An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia.
In response to last week’s DHC Virtual Summit with...
Ep. 008 – Vlad Mkrtumyan Podcast Transcript
Don (PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. I'm your host Don Langsdorf our guest today is Vlad Mkrtumyan....
Pharma Hones its Pandemic Survival Skills—And Everyone Wins
Six months after the Covid -19 pandemic upended health, personal, and economic life for millions around the world, the importance of good, even great...
The DHC Virtual Summit with Novartis | WED, Sept. 30 – THU, Oct. 1...
New Date: The DHC Virtual Summit with Novartis | WED, Sept. 30 - THU, Oct. 1 | 12:00PM - 1:30 PM EDT
This summit will...
3 Ways Video Keeps Reps and HCPs Connected and Engaged
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with...
Video: A Major Driver of U.S. Digital Display Ad Spending Growth in 2020 and...
Despite the COVID-19 pandemic, digital display advertising will continue to grow this year with more investments in video ads. According to eMarketer, U.S. advertisers...
Adapting Customer Engagement Strategies to the COVID Landscape
The pharmaceutical industry has been under pressure for the past decade to change its go-to-market models. While the industry has attempted change, any change...
3 Key Takeaways: DHC Group Omnichannel Roundtable August 2020
https://player.vimeo.com/video/449030264
In the wake of the sales field disruption, DHC Group’s Mark Bard held a roundtable with several physician communication experts to discuss how marketers...
What Happens When 3rd-Party Cookies Expire?
2022 will usher in the demise of third-party cookies—that means pharma brands must change their approach to targeting and measurement.
For decades, the third-party cookie...
